SiNtx Technologies Inc (SINT)

[boston745]

I do realize thats the claim yes. However i have laid down evidence on this forum of the conspiracy, which you are aware of yet do not reference (linked below), so its not like its a baseless claim in regards to Sintx. There is some evidence, which ive posted here unlike so called bears, to suggest management may have been in on it. However unlike you, this does not dissuade me in regards to investing here. As ive said, your viewpoint only helps the conspiracy achieve its endgame, not resist it.
Recent evidence suggests someone disclosed to Lind about the buyback which prompted them to update their warrant holdings months after the RS and Sintx to file the 7.01 when disclosing buyback. Or maybe Sintx disclosed to different party and one of the parties in the know, like Maxim, told Lind. Whichever the case, Sintx disclosed to a party and someone told Lind because the timing of both filings are too close.
11/14/24 : https://www.sec.gov/Archives/edgar/data/1269026/000092963824003929/sch13g.htm
11/18/24: https://www.sec.gov/ix?doc=/Archives/edgar/data/1269026/000149315224046415/form8-k.htm

Then there was the leak from Mr Bray in 2020 which allowed Dr ZB & Sabby (one of the conspiracy of funds) to unload their shares at significantly higher prices before an offering, shares they acquired a month or so beforehand. And of course as i pointed out two posts ago the Employee Share plan conveniently failed before the largest reverse split to date suggesting that was planned out. Of course if it was planned that means Anson, Lind, & the rest of the conspiracy of funds that heavily naked shorted were, at least, working in parallel to make it happen. That said, longterm investors that participated in the rights offerings do have chance to see returns on their investment. Of course so do the investors that jump on now, if now is finally going to be different as suggested by the buyback. That said, because of said conspiracy, its tricky to invest in SINT without being properly hedged. Buyback doesnt mean they will not raise more funds, but if they can raise at significantly higher prices than they bought them back for then that means money well spent.

If management wasnt in on it, then Maxim is and Sintx should be looking for other companies to work with other than Maxim; not sure how easy it is to untangle these relationships. If management is on it, then there are two ways to look at it. Either management is faking it for a paycheck as has been claimed (although evidence does not in fact back this), or they have been trying to scare investors away for some unidentified agenda. Could have been to take Sintx private (unlikely but possible with new CEO), reverse merge with a company, or could have been to keep SINT undervalued and then let those in the know could load up before Zimmer Biomet steps up to see significant returns on their investment.

Savvy investors will take one cursory glance at Sintx and not touch it, this we agree on. Thus if Sintx has been purposefully painted like a penny stock scam as I believe, then those behind it have succeeded. However for those that can look past the shit and see that its a con job, they'll see that Sintx has significant potential and significant companies working with it. Ultimately thats what i care about, Sintx potential to help alot of people but it needs to get moving before shit gets worse! Obviously id like to see a return as well.

If anyone is interested in seeing the list of the conspiracy of funds and when they held shares in Sintx over the last 9+ years, goto this post:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175293704

If you want to look into Sintx partners, i lay out evidence of them here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

Two main things, despite attempts to make Sintx look like a penny stock scam, support the belief that Sintx is not a scam but that a different con job is ongoing to keep people from investing in Sintx. First and foremost is Zimmer & Biomets going on 20 years of working with Sintx. Secondly this study which supports the need of the product across a diverse set of industries. Sintx involvement with NedMedical shows cancer treatment is another industry not listed in the study.

Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.

https://www.mdpi.com/2571-6131/4/2/16/htm

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw